Clinical Trial Update: RELISTOR's Effects on Opioid-Induced Constipation

View source ↗

Summary

The RELISTOR trial evaluating its effects on opioid-induced constipation has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid-induced Constipation

Drugs mentioned

• RELISTOR (methylnaltrexone)

Snippet

Sponsor: Methodist Health System | Conditions: OIC | Status: WITHDRAWN